The National Agency for Food and Drugs Administration and Control (NAFDAC) is informing the public of the circulation of counterfeit Accu-Chek instant Test Strips.
The product was discovered in Jos, and investigations revealed that it originally expired in October 2024 but has been revalidated with a new expiration date of December 2025.
A genuine Accu-Chek Instant is a simple, accurate, and reliable blood glucose monitoring system ideal for people with diabetes.
Please note that the shelf life of Accu-Check is 21 months.
Risk Statement
Using counterfeit Accu-Chek Instant test strips poses significant health risks, primarily due to the potential for inaccurate blood glucose readings, which can lead to dangerous consequences for individuals managing diabetes. These inaccuracies can result in inappropriate medication adjustments, leading to dangerously high or low blood sugar levels.
Product Details
The details of the counterfeit product are as follows.
PRODUCT DETAILS | EXPIRED ACCU-CHEK | REVALIDATED ACCU-CHEK |
Batch Number | 302244 | 302244 |
Expiration Date | 2024-10-04 | 2025-12-23 |
Manufactured Date | 2023-01-03 | 2023-05-16 |
Reference Number | 07819382134 | 510542426288 |
All NAFDAC zonal directors and state coordinators have been directed to conduct surveillance and eliminate counterfeit products within their zones and states.
Importers, distributors, retailers, healthcare professionals, and caregivers are advised to exercise caution and vigilance within the supply chain to prevent the importation, distribution, sale, and use of counterfeit products. All medical products must be obtained from authorized/licensed suppliers. The products’ authenticity and physical condition should be carefully checked.
Healthcare professionals and consumers are advised to report any suspicion of sale of substandard and falsified medicines or medical devices to the nearest NAFDAC office, NAFDAC on 0800-162-3322 or via email: sf.alert@nafdac.gov.ng
Similarly, healthcare professionals and patients are also encouraged to report adverse events or side effects related to the use of medicinal products or devices to the nearest NAFDAC office, or through the use of the E-reporting platforms available on the NAFDAC website www.nafdac.gov.ng or via the Med- safety application available for download on android and IOS stores or via e-mail on pharmacovigilance@nafdac.gov.ng
Furthermore, note that this notice will be uploaded to the WHO Global Surveillance and Monitoring System (GSMS).
NAFDAC………. Customer-focused, Agency-minded!!!
